10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001104659-14-057922`
Period End Date	20140630
Filing Date	20140807
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	cldx-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 68 Cash Flow Statement 56

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$133.58M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$211.57M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$489.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$525.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.72M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.70M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$305.19M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	89.40M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$255.60M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	89.25M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.60M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.97M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	89.40M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	89.25M	shares	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$22.82M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$22.31M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$116.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$148.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$347.10M	USD	Point-in-time
Total Assets	`Assets`	$297.59M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.19M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.24M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$17.18M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$17.90M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.12M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$928.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$21.20M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.95M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$11.07M	USD	Point-in-time
Total Liabilities	`Liabilities`	$27.30M	USD	Point-in-time
Total Liabilities	`Liabilities`	$32.28M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,396,160 and 89,246,832 Shares Issued and Outstanding at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$89.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,396,160 and 89,246,832 Shares Issued and Outstanding at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$89.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$666.33M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$662.72M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.67M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.67M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-345.68M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-403.86M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$265.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$319.80M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$297.59M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$347.10M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$235.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$47.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$200.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$77.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$392.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$100.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$50.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$773.00K	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$2.33M	USD	2 Qtrs
Total Revenue	`Revenues`	$2.51M	USD	2 Qtrs
Total Revenue	`Revenues`	$592.00K	USD	1 Quarter
Total Revenue	`Revenues`	$1.01M	USD	2 Qtrs
Total Revenue	`Revenues`	$97.00K	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$15.09M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$51.17M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$29.18M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$24.10M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$2.33M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.41M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.79M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$9.37M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$6.55M	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$29.14M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$18.75M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$61.05M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$38.57M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-18.66M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-60.04M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-36.06M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-28.55M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$275.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$540.00K	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$161.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.86M	USD	2 Qtrs
Interest Expense	`InterestExpense`	$519.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$829.00K	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.65	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.24	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	77.48M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	80.90M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.36M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.32M	shares	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-2.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$80.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$81.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-194.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-140.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-19.16M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.20M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-36.55M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-58.10M	USD	2 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.27M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.18M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$943.00K	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.16M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.95M	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.44M	USD	2 Qtrs
Gain (Loss) on Sales or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$21.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.76M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.38M	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$97.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-32.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$36.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$424.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.82M	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-250.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-32.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.03M	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$109.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$162.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.32M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-52.73M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.26M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.59M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$20.58M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$126.22M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$88.84M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$917.00K	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.09M	USD	2 Qtrs
Proceeds from Sales or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$21.00K	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-69.16M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-76.73M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$114.19M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$2.29M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$856.00K	USD	2 Qtrs
Payments of Term Loan	`RepaymentsOfSecuredDebt`	$11.03M	USD	2 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$29.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$105.42M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$856.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-3.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-1.00K	USD	2 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-128.60M	USD	2 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$1.00M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$40.80M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.